538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients

Detalles Bibliográficos
Autores principales: Monczor, Ana, Yu, Xiaoying, Vigil, Karen J., Kozinetz, Claudia, Arduino, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
IDWeek 2014 Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781350/
http://dx.doi.org/10.1093/ofid/ofu051.57
_version_ 1783294935310532608
author Monczor, Ana
Yu, Xiaoying
Vigil, Karen J.
Kozinetz, Claudia
Arduino, Roberto
author_facet Monczor, Ana
Yu, Xiaoying
Vigil, Karen J.
Kozinetz, Claudia
Arduino, Roberto
author_sort Monczor, Ana
collection PubMed
description
format Online
Article
Text
id pubmed-5781350
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57813502018-03-01 538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients Monczor, Ana Yu, Xiaoying Vigil, Karen J. Kozinetz, Claudia Arduino, Roberto Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781350/ http://dx.doi.org/10.1093/ofid/ofu051.57 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Monczor, Ana
Yu, Xiaoying
Vigil, Karen J.
Kozinetz, Claudia
Arduino, Roberto
538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
title 538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
title_full 538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
title_fullStr 538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
title_full_unstemmed 538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
title_short 538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
title_sort 538 a retrospective study to evaluate the safety of switching antiretroviral therapy (art) to rilpivirine/tenofovir disoproxil fumarate/emtricitabine (rpv/tdf/ftc) str in virologically suppressed hiv-infected patients
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781350/
http://dx.doi.org/10.1093/ofid/ofu051.57
work_keys_str_mv AT monczorana 538aretrospectivestudytoevaluatethesafetyofswitchingantiretroviraltherapyarttorilpivirinetenofovirdisoproxilfumarateemtricitabinerpvtdfftcstrinvirologicallysuppressedhivinfectedpatients
AT yuxiaoying 538aretrospectivestudytoevaluatethesafetyofswitchingantiretroviraltherapyarttorilpivirinetenofovirdisoproxilfumarateemtricitabinerpvtdfftcstrinvirologicallysuppressedhivinfectedpatients
AT vigilkarenj 538aretrospectivestudytoevaluatethesafetyofswitchingantiretroviraltherapyarttorilpivirinetenofovirdisoproxilfumarateemtricitabinerpvtdfftcstrinvirologicallysuppressedhivinfectedpatients
AT kozinetzclaudia 538aretrospectivestudytoevaluatethesafetyofswitchingantiretroviraltherapyarttorilpivirinetenofovirdisoproxilfumarateemtricitabinerpvtdfftcstrinvirologicallysuppressedhivinfectedpatients
AT arduinoroberto 538aretrospectivestudytoevaluatethesafetyofswitchingantiretroviraltherapyarttorilpivirinetenofovirdisoproxilfumarateemtricitabinerpvtdfftcstrinvirologicallysuppressedhivinfectedpatients

Ejemplares similares